fashion -WSS

fashion

author：knowledge 2025-08-26 23:44:11 - browse：52

Parts of a DNA spotlighted -- Coverage from STAT — Adobe

Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under 20% of its staff, or 19 employees, Flagship confirmed to STAT.

The move comes as Sonata Therapeutics, another Flagship startup, has let go of a third of its staff, part of a broader hunkering down by platform companies. As funding for private biotechs remains scarce, startups hoping to develop new technologies — always an expensive, setback-ridden process — have had to make tough choices on staffing and priorities.

Ring had been particularly ambitious. The company is trying to engineer a new class of viruses as vehicles for delivering genes into patients’ cells. These viruses, tiny bugs called anelloviruses, had the potential to be safer and more versatile than the viruses currently used for gene therapy, called AAVs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Eli Lilly to pay $200M for Beam’s stake in gene

entertainment

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Hospitals warn Medicare's drug payment fix is ‘unlawful’

The FDA weighs the risks of candy

Why Sanofi got shellacked over its spinoff

Chimpanzees, like humans and whales, get menopause: Study

Testing for cancer recurrence creates a new limbo for patients

leisure time

fashion

knowledge

Hollywood unions extend contract negotiations for actors

Problems with a popular proposal to regulate AI in health care

Guidelines to prevent youth baseball injuries need more muscle

Eli Lilly to pay $200M for Beam’s stake in gene

Jerome Adams on the need for new antivirals for Covid

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Walensky prepares to leave CDC — and Congress — behind

A protest over insulin prices is seen as a fight for life

Alkermes shareholders re

Cassava reveals details — and problems — with Alzheimer's study

entertainment

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Readout LOUD: Venture capital, Gilead, and more M&A

Testing for cancer recurrence creates a new limbo for patients

The FDA weighs the risks of candy

Meta's Zuckerberg and Chan on track to put $50 billion into science

Readout Newsletter: New research from Sanofi, Regeneron, etc.

knowledge

explore

entertainment

focus